Want to see HK:0919 full AI Analyst Report?
0919 Stock Chart & Stats
HK$0.08
HK$0.00(0.00%)
At close: 4:00 PM EST
HK$0.08
HK$0.00(0.00%)
Day’s Range― - ―
52-Week RangeHK$0.07 - HK$0.12
Previous CloseN/A
Volume392.00K
Average Volume (3M)71.60K
Market Cap
HK$75.07M
Enterprise Value-HK$132.75M
Total Cash (Recent Filing)HK$305.63M
Total Debt (Recent Filing)HK$43.50M
Price to Earnings (P/E)―
Beta-0.06
Next Earnings
Nov 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding904,483,950
10 Day Avg. Volume65,200
30 Day Avg. Volume71,600
Financial Highlights & Ratios
PEG Ratio0.72
Price to Book (P/B)0.45
Price to Sales (P/S)0.19
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Improved LeverageAn improved debt-to-equity ratio indicates the company has been reducing leverage or growing equity, enhancing financial flexibility. Over 2-6 months this reduces interest burden and bankruptcy risk, enabling more predictable cash allocation to operations, capex, or deleveraging.
Free Cash Flow GrowthSustained free cash flow growth reflects stronger cash conversion from operations, which is durable for funding reinvestment, servicing debt, or absorbing short-term losses. Reliable FCF supports strategic initiatives and provides a buffer while profitability recovers.
Healthy Gross Margins & Stable EquityHealthy gross margins imply enduring product or pricing advantages and room to cover fixed costs, while a stable equity ratio signals a solid asset base. Together these support margin recovery and capital stability over the medium term despite top-line weakness.
Bears Say
Revenue DeclineDeclining revenue growth reduces scale and weakens the firm's ability to cover fixed costs, compressing margins and hindering investment. Over several months this trend can signal demand deterioration or competitive pressure that impedes sustainable recovery and cash generation.
Negative Profitability / ROEPersistent negative net margins and ROE indicate the company is not generating returns on shareholder capital. This undermines reinvestment capacity and shareholder value creation, making funding growth or repairing the balance sheet more challenging over a 2-6 month horizon.
Falling Operating MarginsDeclining EBIT/EBITDA margins point to operational inefficiencies or rising operating costs. Unless structural cost fixes or revenue improvement occur, margin deterioration will persist, limiting free cash flow expansion and constraining strategic flexibility in coming months.
Modern Healthcare Technology Holdings Limited News
0919 FAQ
What was Modern Healthcare Technology Holdings Limited’s price range in the past 12 months?
Modern Healthcare Technology Holdings Limited lowest stock price was HK$0.07 and its highest was HK$0.12 in the past 12 months.
What is Modern Healthcare Technology Holdings Limited’s market cap?
Modern Healthcare Technology Holdings Limited’s market cap is HK$75.07M.
When is Modern Healthcare Technology Holdings Limited’s upcoming earnings report date?
Modern Healthcare Technology Holdings Limited’s upcoming earnings report date is Nov 27, 2026 which is in 138 days.
How were Modern Healthcare Technology Holdings Limited’s earnings last quarter?
Modern Healthcare Technology Holdings Limited released its earnings results on Jun 30, 2026. The company reported -HK$0.009 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.009.
Is Modern Healthcare Technology Holdings Limited overvalued?
According to Wall Street analysts Modern Healthcare Technology Holdings Limited’s price is currently Overvalued.
Does Modern Healthcare Technology Holdings Limited pay dividends?
Modern Healthcare Technology Holdings Limited pays a Notavailable dividend of HK$0.013 which represents an annual dividend yield of N/A. See more information on Modern Healthcare Technology Holdings Limited dividends here
What is Modern Healthcare Technology Holdings Limited’s EPS estimate?
Modern Healthcare Technology Holdings Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Modern Healthcare Technology Holdings Limited have?
Modern Healthcare Technology Holdings Limited has 904,483,950 shares outstanding.
What happened to Modern Healthcare Technology Holdings Limited’s price movement after its last earnings report?
Modern Healthcare Technology Holdings Limited reported an EPS of -HK$0.009 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Modern Healthcare Technology Holdings Limited?
Currently, no hedge funds are holding shares in HK:0919
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Modern Healthcare Technology Holdings Limited
Modern Healthcare Technology Holdings Limited, an investment holding company, provides beauty and wellness services in Hong Kong, Mainland China, Singapore, and Australia. The company operates in two segments, Beauty and Wellness Services, and Skincare and Wellness Products. It offers beauty and facial services; aesthetics services, such as skincare treatment, professional consultation, skin care and anti-ageing, and referral services on plastic reconstruction; slimming services, including weight management programs; spa and massage services comprising resplendent bathroom furnishings and a hydrotherapeutic pool, as well as foot spa, and foot treatment and massage services; and haircare and removal, make-up, joint and intimate care, and body check and genetic test services. The company also sells skincare and wellness products under the be, FERRECARE, p.e.n, Y.U.E., Advanced Natural, Malu Wilz, Byotea, Care Plus, Mu-lan Spa, Cellnoc, Veribel, Castille, Dr Plus, IconX, Eclat du teint, and Natural Care brand names. In addition, it provides sub-franchising services in relation to beautification and gymnastic services; beauty and wellness treatment training program; property holding services; food and beverage services; fund management services; advertising services; maid agency services; licensing services; and management services, as well as holds property leases. The company was formerly known as Modern Beauty Salon Holdings Limited and changed its name to Modern Healthcare Technology Holdings Limited. The company was incorporated in 2005 and is headquartered in Kowloon Bay, Hong Kong.
Technical Analysis
Fu Shou Yuan International Group
―
Perfect Medical Health Management Limited
―
Sino-Life Group Limited
―
Max Sight Group Holdings Limited
―
Shenghui Cleanness Group Holdings Limited
―